These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38130636)

  • 1. Impact of gut microbiota and associated mechanisms on postprandial glucose levels in patients with diabetes.
    Feng X; Deng M; Zhang L; Pan Q
    J Transl Int Med; 2023 Dec; 11(4):363-371. PubMed ID: 38130636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of gut microbiota-derived metabolites in gestational diabetes mellitus and clinical significance.
    Gao Y; Chen H; Li J; Ren S; Yang Z; Zhou Y; Xuan R
    J Clin Lab Anal; 2022 Apr; 36(4):e24333. PubMed ID: 35285096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.
    Palmnäs-Bédard MSA; Costabile G; Vetrani C; Åberg S; Hjalmarsson Y; Dicksved J; Riccardi G; Landberg R
    Am J Clin Nutr; 2022 Oct; 116(4):862-874. PubMed ID: 36026526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-gut microbiota interactions on cardiovascular disease.
    Zhang X; Gérard P
    Comput Struct Biotechnol J; 2022; 20():1528-1540. PubMed ID: 35422966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.
    Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X
    Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms.
    Liu S; He Y; Zhang Y; Zhang Z; Huang K; Deng L; Liao B; Zhong Y; Feng J
    Gut Microbes; 2023 Dec; 15(2):2290331. PubMed ID: 38073096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial metabolites and heart failure: Friends or enemies?
    Lu X; Liu J; Zhou B; Wang S; Liu Z; Mei F; Luo J; Cui Y
    Front Microbiol; 2022; 13():956516. PubMed ID: 36046023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes.
    Chen Y; Wang M
    Drug Des Devel Ther; 2021; 15():4849-4863. PubMed ID: 34876807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.
    Lyu M; Wang YF; Fan GW; Wang XY; Xu SY; Zhu Y
    Front Microbiol; 2017; 8():2146. PubMed ID: 29167659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD).
    Yoo JY; Sniffen S; McGill Percy KC; Pallaval VB; Chidipi B
    Microorganisms; 2022 Jan; 10(1):. PubMed ID: 35056557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.
    Zhu J; Lyu J; Zhao R; Liu G; Wang S
    Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites.
    Zhang W; Dong XY; Huang R
    Transl Stroke Res; 2023 Dec; 14(6):811-828. PubMed ID: 36279071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Gut Microbiota in Neuroendocrine Regulation of Carbohydrate and Lipid Metabolism via the Microbiota-Gut-Brain-Liver Axis.
    Wang SZ; Yu YJ; Adeli K
    Microorganisms; 2020 Apr; 8(4):. PubMed ID: 32272588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
    Chaikijurajai T; Tang WHW
    Curr Heart Fail Rep; 2021 Apr; 18(2):23-32. PubMed ID: 33559845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids metabolism involved in the beneficial effects of Danggui Shaoyao San via gut microbiota in the treatment of CCl
    Zhao Y; Zhao M; Zhang Y; Fu Z; Jin T; Song J; Huang Y; Zhao C; Wang M
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117383. PubMed ID: 37925004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus.
    Gao R; Meng X; Xue Y; Mao M; Liu Y; Tian X; Sui B; Li X; Zhang P
    Front Pharmacol; 2022; 13():1027212. PubMed ID: 36386219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Gut Microbiota and Cardiovascular Disease.
    Murphy K; O'Donovan AN; Caplice NM; Ross RP; Stanton C
    Metabolites; 2021 Jul; 11(8):. PubMed ID: 34436434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort.
    Org E; Blum Y; Kasela S; Mehrabian M; Kuusisto J; Kangas AJ; Soininen P; Wang Z; Ala-Korpela M; Hazen SL; Laakso M; Lusis AJ
    Genome Biol; 2017 Apr; 18(1):70. PubMed ID: 28407784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.